Covered recipient · General Payments record
IMRAN JAWAID
Allopathic & Osteopathic Physicians Internal Medicine Nephrology
General Payments · PY2021–2024
$1,410.45
- Reported across 69 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $598.22 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $142.26 | 9 |
| CALLIDITAS THERAPEUTICS US INC. | $135.23 | 2 |
| Amgen Inc. | $96.06 | 5 |
| Novo Nordisk AS | $77.92 | 3 |
| Aurinia Pharma U.S., Inc. | $34.86 | 2 |
| Alexion Pharmaceuticals, Inc. | $31.46 | 2 |
| Averitas Pharma Inc. | $28.54 | 1 |
| SANOFI-AVENTIS U.S. LLC | $23.84 | 1 |
| Acerta Pharma LLC | $14.31 | 1 |
| Radius Health, Inc. | $13.74 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $14.44 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094031394 | CMS |
| Alexion Pharmaceuticals, Inc. | $17.02 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093885859 | CMS |
| Amgen Inc. | $20.47 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111608905 | CMS |
| Amgen Inc. | $19.49 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111608911 | CMS |
| Amgen Inc. | $21.11 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111608907 | CMS |
| Amgen Inc. | $21.00 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111608913 | CMS |
| Amgen Inc. | $13.99 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111608909 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.31 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105491801 | CMS |
| Aurinia Pharma U.S., Inc. | $21.57 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150683634 | CMS |
| Aurinia Pharma U.S., Inc. | $13.29 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150683636 | CMS |
| Averitas Pharma Inc. | $28.54 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133430908 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $21.90 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141518131 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $113.33 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141518965 | CMS |
| Novo Nordisk Inc | $24.46 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096961318 | CMS |
| Novo Nordisk Inc | $23.42 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097318022 | CMS |
| Novo Nordisk Inc | $30.04 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097473582 | CMS |
| Radius Health, Inc. | $13.74 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089956002 | CMS |
| SANOFI-AVENTIS U.S. LLC | $23.84 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139734552 | CMS |
| UCB, Inc. | $17.55 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143261787 | CMS |
| UCB, Inc. | $21.31 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143261792 | CMS |
| UCB, Inc. | $21.51 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143261796 | CMS |
| UCB, Inc. | $0.23 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143261800 | CMS |
| UCB, Inc. | $22.44 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143261805 | CMS |
| UCB, Inc. | $0.40 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143261809 | CMS |
| UCB, Inc. | $19.08 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143261814 | CMS |
| UCB, Inc. | $20.19 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143261818 | CMS |
| UCB, Inc. | $19.55 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143261823 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.